newsfilter
← Latest News
Business Wire·

Iveric Bio Announces FDA Accepts New Drug Application and Grants Priority Review for Avacincaptad Pegol for the Treatment of Geographic Atrophy

- PDUFA goal date is August 19, 2023 - IVERIC bio, Inc. (NASDAQ:ISEE) today announced that the U.S. Food and Drug Administration (FDA) has completed its filing review and accepted the company's New Drug Application